Literature DB >> 21191587

Irreversible electroporation in a Swine lung model.

Damian E Dupuy1, Bassam Aswad, Thomas Ng.   

Abstract

PURPOSE: This study was designed to evaluate the safety and tissue effects of IRE in a swine lung model.
METHODS: This study was approved by the institutional animal care committee. Nine anesthetized domestic swine underwent 15 percutaneous irreversible electroporation (IRE) lesion creations (6 with bipolar and 3 with 3-4 monopolar electrodes) under fluoroscopic guidance and with pancuronium neuromuscular blockade and EKG gating. IRE electrodes were placed into the central and middle third of the right mid and lower lobes in all animals. Postprocedure PA and lateral chest radiographs were obtained to evaluate for pneumothorax. Three animals were sacrificed at 2 weeks and six at 4 weeks. Animals underwent high-resolution CT scanning and PA and lateral radiographs 1 h before sacrifice. The treated lungs were removed en bloc, perfused with formalin, and sectioned. Gross pathologic and microscopic changes after standard hematoxylin and eosin staining were analyzed within the areas of IRE lesion creation.
RESULTS: No significant adverse events were identified. CT showed focal areas of spiculated high density ranging in greatest diameter from 1.1-2.2 cm. On gross inspection of the sectioned lung, focal areas of tan discoloration and increased density were palpated in the areas of IRE. Histological analysis revealed focal areas of diffuse alveolar damage with fibrosis and inflammatory infiltration that respected the boundaries of the interlobular septae. No pathological difference could be discerned between the 2- and 4-week time points. The bronchioles and blood vessels within the areas of IRE were intact and did not show signs of tissue injury.
CONCLUSION: IRE creates focal areas of diffuse alveolar damage without creating damage to the bronchioles or blood vessels. Short-term safety in a swine model appears to be satisfactory.

Entities:  

Mesh:

Year:  2010        PMID: 21191587     DOI: 10.1007/s00270-010-0091-9

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  11 in total

1.  Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties.

Authors:  Eliel Ben-David; Muneeb Ahmed; Mohammad Faroja; Marwan Moussa; Ayelet Wandel; Jacob Sosna; Liat Appelbaum; Isaac Nissenbaum; S Nahum Goldberg
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

Review 2.  Alternative to surgery in early stage NSCLC-interventional radiologic approaches.

Authors:  Kyungmouk Steve Lee; Bradley B Pua
Journal:  Transl Lung Cancer Res       Date:  2013-10

3.  [Irreversible electroporation - a new kid on the block?].

Authors:  O Kosiek; K Strach; J Ricke; M Pech
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

4.  In vivo evaluation of bronchial injury of irreversible electroporation in a porcine lung ablation model by using laboratory, pathological, and CT findings.

Authors:  Jun-Hui Sun; Tong-Yin Zhu; Xin-Hua Chen; Chun-Hui Nie; Zhi-Gang Ren; Guan-Hui Zhou; Tan-Yang Zhou; Sheng-Yong Yin; Zhi-Yi Peng; Li-Ming Wu; Xiong-Xin Zhang; Wei-Lin Wang; Shu-Sen Zheng
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

5.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.

Authors:  Muneeb Ahmed; Luigi Solbiati; Christopher L Brace; David J Breen; Matthew R Callstrom; J William Charboneau; Min-Hua Chen; Byung Ihn Choi; Thierry de Baère; Gerald D Dodd; Damian E Dupuy; Debra A Gervais; David Gianfelice; Alice R Gillams; Fred T Lee; Edward Leen; Riccardo Lencioni; Peter J Littrup; Tito Livraghi; David S Lu; John P McGahan; Maria Franca Meloni; Boris Nikolic; Philippe L Pereira; Ping Liang; Hyunchul Rhim; Steven C Rose; Riad Salem; Constantinos T Sofocleous; Stephen B Solomon; Michael C Soulen; Masatoshi Tanaka; Thomas J Vogl; Bradford J Wood; S Nahum Goldberg
Journal:  J Vasc Interv Radiol       Date:  2014-10-23       Impact factor: 3.464

Review 6.  Lung cancer ablation: what is the evidence?

Authors:  Thierry de Baere; Geoffroy Farouil; Frederic Deschamps
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 7.  Lung cancer ablation: technologies and techniques.

Authors:  Erica S Alexander; Damian E Dupuy
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

8.  Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.

Authors:  Christoph Niessen; Ernst Michael Jung; Walter A Wohlgemuth; Benedikt Trabold; Michael Haimerl; Andreas Schreyer; Christian Stroszczynski; Philipp Wiggermann
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

Review 9.  Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors.

Authors:  Kanishka Rangamuwa; Tracy Leong; Clare Weeden; Marie-Liesse Asselin-Labat; Steven Bozinovski; Michael Christie; Tom John; Phillip Antippa; Louis Irving; Daniel Steinfort
Journal:  Transl Lung Cancer Res       Date:  2021-06

10.  Immunologic response to tumor ablation with irreversible electroporation.

Authors:  Xiaoxiang Li; Kui Xu; Wei Li; Xiuchun Qiu; Baoan Ma; Qingyu Fan; Zhao Li
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.